To determine the effect of neighborhood ethnic composition on power wheelchair prescriptions. DESIGN: The 5% noncancer sample of Medicare recipients in the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database, from 1994 to 2001. SETTING: SEER regions. PARTICIPANTS: Individuals covered by Medicare living in SEER regions without a cancer diagnosis. MEASUREMENTS: Individual characteristics (age, sex, ethnicity, justifying diagnosis, and comorbidity), primary diagnoses, neighborhood characteristics (percentage black, percentage Hispanic, percentage with o12 years education, and median income), and SEER region. RESULTS: The rate of power wheelchair prescriptions was 33 times greater in 2001 than in 1994, with a shift over time from justifying diagnoses more closely tied to mobility impairment, such as strokes, to less-specific medical diagnoses, such as osteoarthritis. In multilevel, multivariate analyses, individuals living in neighborhoods with higher percentages of blacks or Hispanics were more likely to receive power wheelchairs (odds ratios 5 1.09 for each 10% increase in black residents and 1.23 for each 10% increase in Hispanic residents) after controlling for ethnicity and other characteristics at the individual level. CONCLUSION: These results support allegations that marketers promoting power wheelchairs have specifically targeted minority neighborhoods. J Am Geriatr Soc 55: 221-226, 2007. 
H ealth insurance fraud was estimated in 2003 to cost $50 billion to $85 billion in the United States. 1 Fraud and abuse contribute to rising costs of the Medicare and Medicaid programs, but there has been little systematic study of this issue. 2, 3 This report focuses on one example of fraud and abuse, involving claims and reimbursement by Medicare for power wheelchairs.
Medicare covers power wheelchairs, including motorized scooters, for patients with severe mobility impairment who cannot operate a manual wheelchair. 4 Over the past several years, there have been a number of complaints alleging fraud and abuse in the power wheelchair program. [5] [6] [7] This led to investigations by the General Accounting Office and the Office of Inspector General of the U.S. Department of Health and Human Services. 4, 8, 9 There has been considerable concern raised about improper marketing of power wheelchairs. 5, 10 There were allegations that minority neighborhoods were targeted, using door-to-door solicitation, and that fully ambulatory older residents were offered kickbacks for participating and bounties for recruiting others. 10 These individuals were then directed to specific physicians, some of whom also received kickbacks from the power wheelchair distributors. 7, 11 One factor contributing to the abuse was the large profit margin for suppliers of power wheelchairs. Medicare was paying more than $5,000 per power wheelchair claim in 2003, whereas the Department of Veterans Affairs paid closer to $3,000 per chair, 8 which suggests that there was substantial profit in power wheelchairs reimbursed by Medicare.
Although Medicare reimbursement for power wheelchairs grew from less than $150 million in 1997 to more that $1.1 billion in 2003, the specific pattern of growth in power wheelchair claims has not been described in detail. 4 This article examines the growth in wheelchair prescriptions from 1994 through 2001. Whether the pattern of diagnoses used to justify the prescription of power wheelchairs changed over time, from diagnoses clearly tied to mobility impairment such as multiple sclerosis, strokes, and amputation to less-specific diagnoses such as osteoarthritis, was examined. Whether there was evidence of targeting minority neighborhoods, as suggested in press reports, was also examined. 7 Using multilevel analysis, the effect of neighborhood ethnic composition on power wheelchair prescriptions was assessed, independent of the ethnicity of the individual. It was hypothesized that prescriptions for power wheelchairs would be highest in minority neighborhoods.
PATIENTS AND METHODS

Data Sources and Study Sample
Data from the 5% noncancer control subjects included in the Surveillance, Epidemiology and End Results (SEER)-Medicare database were analyzed. 12 The 5% control sample included in the SEER database contains relevant Medicare files and is linked to the 2000 Census data. In the 1990s, the SEER program consisted of a group of 11 tumor registries (the metropolitan areas of Atlanta, Detroit, Los Angeles, San Jose, San Francisco/Oakland, and Seattle and the states of Connecticut, Hawaii, Iowa, New Mexico, and Utah), representing approximately 14% of the U.S. population. The data used in this study included the Medicare Enrollment file, the Medicare Provider Analysis and Review file (hospital inpatient claims), the Outpatient file (outpatient claims), the Carrier File (physician services claims), and the Durable Medical Equipment file (claims submitted to durable medical equipment regional carriers). Medicare recipients in SEER areas are similar to the U.S. Medicare population, with a somewhat larger percentage of nonwhites and urban dwellers. 12, 13 All subjects with at least 1 month of Medicare Parts A and B coverage (wheelchair is a Part B benefit), not a member of a health maintenance organization that month, and residing in one of the SEER areas between 1994 and 2001 were included in the initial sample. The sample was further refined by excluding subjects who were not enrolled in both Medicare Parts A and B in the 12 months before each study year (11, 556 person-years) and were members of a health maintenance organization (10,186 person-years).
To examine the relationships between power wheelchair prescriptions and neighborhood characteristics, the SEER-Medicare data were linked with the 2000 U.S. Census data. The linkage was based on subjects' ZIP code from Medicare enrollment data for each year. This linkage included only Medicare subjects aged 65 and older during the period 1999 through 2001 and allowed persons with and without power wheelchair claims to be compared during a defined period when power wheelchair prescription rates were at their highest levels. The study month for subjects with a power wheelchair claim was the month of the prescription. The study month for subjects without a power wheelchair claim was randomly assigned from a given year. The institutional review board of the University of Texas Medical Branch, Galveston, Texas, granted approval of this study. De-identified data were used in the analyses, and individual subject consent was not required.
Data Collection and Measures
The primary outcome was rate of power wheelchair claims (Health Care Procedure Coding System code K0011) from 1994 to 2001. Power wheelchair claims were calculated as the number of claims submitted divided by all eligible person-years in the Medicare Enrollment file. Submitted claims were used in the analyses instead of paid claims to obtain a more-complete record of services received. Medicare paid for between 89% and 91% of the submitted claims included in the analyses. The primary claim diagnosis code in the Durable Medical Equipment file was used to assess reasons for the wheelchair prescription. For some analyses, the diagnoses were dichotomized into two groups: neurological/orthopedic and medical. The neurological/orthopedic category included stroke, Parkinson's disease, cerebral palsy, multiple sclerosis, spinal cord injury, other paralytic syndromes, amputations, and fractures. The medical category included hypertension, cardiac and pulmonary diseases, arthritis and related diseases, endocrine and metabolic diseases, and others (Table 1) .
Potential moderating variables were characteristics of the individual and neighborhood or environmental factors. Individual characteristics were age, sex, ethnicity, region, and comorbid conditions. A comorbidity index was calculated using Klabunde's method, using the Medicare inpatient and outpatient physician claim data.
14 Ethnicity was categorized as non-Hispanic white, black, Hispanic, and other (Asian, Native American, and unknown). Unlike the U.S. Census, Medicare does not separate race and ethnicity. Hispanics must choose between Hispanic and some other race. This results in underreporting of Hispanics in Medicare data relative to census data. 15 Neighborhood and environmental factors obtained from the linkage with the U.S. Census data included median income, percentage of adults with less than 12 years education, percentage black, and percentage Hispanic. Neighborhood characteristics were aggregated at the level of ZIP code for the purpose of statistical analyses.
Statistical Analyses
Descriptive statistics were used to explore the unadjusted rates of wheelchair claims and the primary diagnosis for claims. The comparison of neighborhood and sociodemographic characteristics between persons with and without power wheelchair claims (1999-2001) was conducted using hierarchical generalized linear models (HGLMs). HGLMs were computed for all eligible neighborhoods with at least five subjects. Five subjects is considered sufficient for leveltwo variables when fixed effects are being tested. 16, 17 The analyses were also repeated using only neighborhoods with at least 125 subjects, and the same patterns were found as reported here. Analyses were performed using SAS version 9.1 (SAS Institute, Inc., Cary, NC).
RESULTS
Time Trend in Claims for Power Wheelchairs from 1994 to 2001
There were 1,166,325 person-years available for this analysis. Power wheelchairs claims were 33 times higher in 2001 (3.60 per 1,000) than in 1994 (0.11 per 1,000 Medicare patients per year). Table 1 presents the primary diagnoses used to justify the power wheelchair prescriptions. Neurological and orthopedic diagnoses accounted for slightly fewer than 40% of all wheelchair claims, whereas hypertension, cardiopulmonary diseases, arthritis, and endocrine or metabolic diseases accounted for approximately 60%. The table includes Medicare subjects of all ages, that is, those aged 65 and older enrolled in traditional Medicare and those younger than 65 who were eligible for Medicare, because they were considered disabled under Social Security provisions. The use of a medical (vs neurological or orthopedic) diagnosis as justification for power wheelchair prescriptions was higher in those aged 65 and older than in younger patients (67.6% vs 48.7%, Po.001). The use of a medical diagnosis was also higher in nonwhites (67.0%) than whites (57.7%, Po.001) and in women (59.9%) than men (40.1%, Po.001). Figure 1 traces the growth in all power wheelchair claims by year and stratified by whether the primary diagnosis justifying the prescription was neurological/orthopedic or medical. The major growth in wheelchair claims during the period of study was in patients with a medical diagnosis (Po.001). In 1994 to 1996, 33.3% of the power wheelchair claims were for a medical diagnosis, whereas by 2001, 68% were for patients with a medical diagnosis. Of the medical diagnoses, 41.3% were for osteoarthritis or nonspecific or unspecified joint or back problems.
The relationship between ethnicity, income, and educational status and power wheelchair prescriptions was next examined. Ethnicity was examined at an individual level and at a neighborhood level (percentage black and percentage Hispanic in ZIP code of residence), whereas income and education were only examined at the level of the ZIP code. Analyses were limited to Medicare patients aged 65 and older for 1999 to 2001, because those were the years reflecting the greatest increase in prescriptions (two-thirds of all power wheel chair prescriptions from 1994 to 2001 were in 1999 to 2001), and older patients were alleged to be specific targets for power wheelchair marketers. There were 367,468 person-years available for this analysis. Bivariate analyses were performed to look for associations between demographic or neighborhood characteristics and wheelchair claims. Black patients were about six times as likely to receive a power wheelchair during 1999 to 2001 as were whites, with Hispanic patients having a rate in between. Residents of the south were more than six times as likely to receive power wheelchairs as those in the northeast or midwest. Power wheelchair claims were also more common in neighborhoods with low income, low education, or higher percentages of black or Hispanic residents. Table 2 presents multivariable HGLM analyses of odds of receiving a power wheelchair. In Model 1, only individual characteristics are included, whereas Model 2 is a multilevel analysis including characteristics of the neighborhood environment. In Model 1, there are clear associations between greater power wheelchair use and older age, male sex, black race, and increasing comorbidity. Prescriptions were also substantially greater in the south and west than in the northeast and midwest. The higher rate of power wheelchair use for Hispanics seen in the bivariate analyses is no longer seen after controlling for other individual characteristics in Model 1. Model 2 shows that the overall ethnic composition of the neighborhood was a major predictor of power wheelchair prescriptions independent of ethnicity at the individual level of the residents of the neighborhood. Each 10% increase in percentage of black residents was associated with a 9% increase in wheelchair prescriptions, whereas each 10% increase in percentage of Hispanic residents was associated with a 23% increase in power wheelchair prescriptions. Adding neighborhood ethnicity, poverty (income), and education variables had little effect on the odds associated with individual characteristics.
The HGLM analyses in Table 2 were repeated, restricting the dependent variable to those receiving power wheelchairs for a medical (i.e., not neurological or orthopedic) diagnosis. The odds associated with year, age, ethnicity, region, and comorbidity were similar to those shown in Table 2 . The effect of sex was eliminated (odds of receiving power wheelchairs for women versus men 5 0.98, 95% confidence interval (CI) 5 0.89-1.07), whereas the effect of neighborhood percentage of black (odds ratio (OR) 5 1.13, 95% CI 5 1.05-1.22) and Hispanic (OR 5 1.28, 95% CI 5 1.19-1.39) was somewhat higher than in the analysis of power wheelchairs prescribed for any diagnosis.
DISCUSSION
Fraud and abuse of third-party payers by providers of healthcare services are increasingly recognized as a serious problem in American medicine. [1] [2] [3] 10, 18 Fraud typically is a criminal offense and involves the knowing intent to deceive for financial gain. Abuse includes providing unnecessary services or services that fail to meet recognized standards. 18 There are remarkably few studies of fraud and abuse, presumably because they are difficult to establish. 2, 3 In that regard, it should be noted that none of the data presented in these analyses establish the existence of fraud or abuse. Instead, the pattern of prescriptions for power wheelchairs in this population-based sample was consistent with the allegations in press reports and federal investigations. [4] [5] [6] [7] [8] [9] [10] [11] 19 Specifically, a rapid increase in power wheelchair use was found from 1994 to 2001. This increase was mostly in recipients whose justification was relatively loosely tied to the Medicare criteria for power wheelchairs (i.e., those with diagnoses of osteoarthritis or cardiopulmonary disease rather than those with neurological conditions). The most striking finding was the association between wheelchair prescriptions and neighborhood concentration of black and Hispanic ethnicity. In multivariable, multilevel analyses, black ethnicity was associated with 2.78 greater odds of receiving a wheelchair. In addition, Medicare enrollees living in neighborhoods with higher concentrations of blacks had higher odds of receiving a wheelchair, independent of their individual ethnicity. The effect of Hispanic ethnicity was entirely at the neighborhood level. In multivariable, multilevel analyses, Hispanic ethnicity was not associated with greater odds of receiving a wheelchair (OR 5 0.81, 95% CI 5 0.64-1.01), but Medicare enrollees in neighborhoods with higher concentrations of Hispanics had greater odds of receiving a wheelchair (OR 5 1.23, 95% CI 5 1.15-1.31 for each 10% increase in percentage of residents who were Hispanic).
Alternatively, black ethnicity was associated with greater odds of power wheelchair prescriptions at the individual and neighborhood level. The higher rates of disability experienced by blacks might partially explain the greater rate of power wheelchair prescriptions for this group. 20 Hispanics are also at greater risk for disability than non-Hispanic whites, 21, 22 but this was not reflected in a greater rate of power wheelchair prescription for this group. There seems to be no plausible medical explanation for the higher rate of power wheelchairs by residents of minority neighborhoods, independent of individual ethnicity.
The targeting of minority neighborhoods, especially Hispanic neighborhoods, has been noted in press reports. For example, a recent New York Times article described Figure 1 . Rate of wheelchair prescriptions for Medicare enrollees in the 5% noncancer sample residing in Surveillance, Epidemiology, and End Results areas stratified by whether the justifying diagnosis was medical or neurological/orthopedic. The change in rate for wheelchair prescriptions justified by a medical diagnosis was significantly greater than that for a neurological or orthopedic diagnosis (Po.001 according to chi-square analysis).
how recruiters canvased Mexican-American neighborhoods in Arizona, offering kickbacks and organizing busloads of residents who would travel to California to receive multiple unnecessary surgeries at several outpatient surgical centers. 1 Another striking finding was the geographic variation in rate of power wheelchair prescriptions. Given the marked discrepancies between regions, there is concern that the rapid growth in the south and west could be duplicated in the northeast and midwest.
As noted above, these data cannot prove fraud or abuse. The Office of the Inspector General for the Department of Health and Human Services audited 300 randomly selected claims for power wheelchairs from 2001, contacting suppliers, physicians, and recipients for additional information. 4 Almost one-third of the claims failed to meet criteria, even for a standard nonmotorized wheelchair. Another 45% met criteria for a standard wheelchair. Only 13% met Medicare criteria for a power wheelchair. Twentyeight percent of recipients stated they were not using the wheelchairs or were using them only outside the home. These findings clearly demonstrate widespread abuse of the system.
There are a number of regulations in place designed to curb abuse. These include a statute forbidding telephone solicitation by durable medical equipment suppliers and forbidding providers from waiving the 20% copayment. In addition, the prescription of one form of motorized wheelchair, the scooter, is supposed to be limited to certain specialists. 23 Such restrictions have been linked to less abuse in other settings. 2 Changing the Medicare reimbursement rate is another proposed strategy to reduce potential abuse. 4 In 2004, the Medicare rate for the most popular power wheelchair, a K-11 model, was $5,297. The same wheelchair could be purchased on-line for $3,863, from wholesalers for $2,363, and from distributors and manufacturers for $1,550. 4 Perhaps the most difficult problem in combating abuse is applying rigid criteria to complex clinical situations. There is no doubt that power wheelchairs represent a major advance that has had a dramatic effect on the quality of life and independence of many persons with severe mobility impairment. Healthcare insurers must construct relatively rigid criteria that dichotomize patients with a complex spectrum of needs into those who do and do not qualify. Some individuals who do not meet Medicare criteria might still benefit from a power wheelchair. Alternatively, leaving the decision as to whether an individual should receive reimbursement for a power from Medicare up to his or her personal physician or any other physician does not seem to be working, particularly in the face of aggressive marketing to the public emphasizing the message that individuals deserve power wheelchairs as part of their rights under Medicare.
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CONCLUSION
In conclusion, there was a rapid rise in power wheelchair prescriptions between 1994 and 2001, coincident with growing reports of abuse in this area. Recent efforts by the Centers for Medicare and Medicaid Services to tighten the process of power wheelchair prescriptions may be successful in reducing the abuse. 24 Successful efforts to combat abuse may require more-active participation of the medical community, working with third-party payers such as Medicare, to design and test programs to identify and control abuse within the payment systems. This study shows how administrative datasets can be used to more fully describe the pattern of use of medical technologies, which may in turn provide evidence to combat potential abuse. Author Contributions: J. Goodwin directed the conception and design, data analysis, preparation of manuscript, and final approval of version to be published. K. Ottenbacher contributed to the study design, data analysis, and preparation of manuscript; Y.-F. Kuo contributed to data analysis and interpretation and manuscript preparation. T. Nguyen-Oghalai contributed to study design, data acquisition, analysis and interpretation, and manuscript preparation.
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